This represents one important method by which the efficacy of drugs used for SQTS treatment can be evaluated in hiPSC‐CMs with mutant Kv11.1 or multiple ion channels to predict effects in SQTS patients.171. Here, KCNH2 is linked to Familial short QT syndrome.